Range Cancer Therapeutics ETF to Close and Liquidate

Strategic Insights -

The Range Cancer Therapeutics ETF, offered by Exchange Traded Concepts, LLC, has been ordered to close and liquidate its assets by the ETF Series Solutions Board of Trustees. The liquidation is set to take place on May 27, 2025, and shares of the fund will no longer be traded on The Nasdaq Stock Market LLC. The liquidation is a result of the fund's deviation from its stated investment objectives and strategies, and shareholders may face difficulties in selling their shares before the liquidation date. The distribution of cash to remaining shareholders will be a taxable event, and investors are advised to consult their tax advisors to discuss the income tax consequences of the liquidation.

Key Takeaways:

  • The Range Cancer Therapeutics ETF will close and liquidate its assets on May 27, 2025.
  • Shares of the fund will no longer be traded on The Nasdaq Stock Market LLC prior to the liquidation date.
  • Shareholders may face difficulties in selling their shares before the liquidation date.
  • The distribution of cash to remaining shareholders will be a taxable event.
  • Investors are advised to consult their tax advisors to discuss the income tax consequences of the liquidation.
  • The liquidation is a result of the fund's deviation from its stated investment objectives and strategies.
  • Exchange Traded Concepts, LLC serves as the investment advisor to the fund, and Quasar Distributors, LLC is the distributor.
  • Investors should contact 1-800-617-0004 for additional information and to obtain the fund's prospectus.

Statistics:

  • The liquidation date is set for May 27, 2025.
  • The fund's net asset value will reflect the costs of closing the fund, if any, on the liquidation date.
  • The distribution of cash to remaining shareholders is expected to take place promptly after the liquidation date.

Sources:

  • ETF Series Solutions, Board of Trustees
  • Exchange Traded Concepts, LLC
  • Quasar Distributors, LLC
  • Source: Exchange Traded Concepts, LLC, https://rt.prnewswire.com/rt.gif?NewsItemId=DA82802&Transmission_Id=202505080830PR_NEWS_USPR_____DA82802&DateId=20250508